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ORIGINAL INVESTIGATION
Factors Associated With Dietary Supplement Use
Among Prescription Medication Users
Paula Gardiner, MD; Robert E. Graham, MD, MPH; Anna T. R. Legedza, ScD;
David M. Eisenberg, MD; Russell S. Phillips, MD
Background: We examined the patterns of nonvita-
min dietary supplement (NVDS) use among adult pre-
scription medication users in the United States.
Methods:Using the 2002National Health Interview Sur-
vey, we analyzed factors associated with NVDS use and
prescriptionmedication use in the prior 12months with
descriptive, 2, and logistic regression analysis.
Results: In the United States, 21% of adult prescription
medication users reported using NVDSs in the prior 12
months. Of the respondents who used both prescription
medications and NVDSs in the prior 12 months, 69% did
not discuss this use with a conventional medical practi-
tioner. Among adults who used prescription medications
in the prior 12 months, the most commonly used supple-
ments included echinacea, ginseng, ginkgo, garlic, and glu-
cosamine chondroitin. Prescriptionmedication userswith
menopause and chronic gastrointestinal disorders had the
highest rates of NVDS use (33% and 28%, respectively),
and prescriptionmedicationuserswith coronary heart dis-
ease and history of myocardial infarction had the lowest
rates of use (12% each). In the adjusted analysis, factors
associated with increased use of NVDSs by prescription
medication users included being female, being Hispanic,
having more years of education, living in the West, lack-
ingmedical insurance, and having chronic conditions. El-
derly respondents were less likely to use NVDSs.
Conclusion:One in 4 prescriptionmedication users took
an NVDS in the prior 12 months, yet the majority did
not share this with a conventional medical professional.
Arch Intern Med. 2006;166:1968-1974
A CCORDING TO THE OFFICEof Dietary Supplements ofthe National Institutes ofHealth, a dietary supple-ment i s in tended to
supplement the diet and contains 1 or
more dietary ingredients (including vita-
mins, minerals, herbs or other botani-
cals, amino acids, and other substances)
or their constituents.1 Analyses of the Na-
tional Health Interview Survey (NHIS)
have estimated that 10% to 19% of the US
population use nonvitamin dietary supple-
ments (NVDSs) for health conditions.2,3
Rates of dietary supplement use vary by
age, sex, and race/ethnicity, but substan-
tial numbers of all patient groups report
using dietary supplements, particularly
among those with chronic or recurrent ill-
nesses who also receive care by conven-
tional health care professionals.4,5 Pa-
tientswith chronic illness are also frequent
users of prescription medications. De-
spite increasing concern about poten-
tially harmful interactions between di-
etary supplements and prescription
medications based on case reports and
clinical observation, little clinical evi-
dence is available to help the health care
professional know which of their pa-
tients are at risk.6
Few studies have examined the use of
NVDSs amongUS adult prescriptionmedi-
cation users.7 Using data from a nationally
representative survey, we examined over-
all prevalence and patterns ofNVDSuse by
prescription medication users, disclosure
ratesofNVDSuseamongprescriptionmedi-
cation users to health care professionals,
prevalenceof use of specific herbs andother
dietary supplements taken by prescription
medication users, chronic medical condi-
tions in which NVDS use and prescription
medication use occurs together, and fac-
tors associatedwithNVDSuse by prescrip-
tion medication users.
METHODS
DATA SOURCE
Weanalyzed data from the sample core compo-
nent and the Alternative Health/Complemen-
tary andAlternativeMedicine supplement to the
2002 NHIS,8 which was administered as part
of the sample adult questionnaire of the 2002
NHIS. The NHIS is an in-person household
survey conducted by the Census Bureau for
the National Center for Health Statistics and is
the principal source of information in the
United States on the health of the civilian,
noninstitutionalized, household population.
Author Affiliations: Division
for Research and Education in
Complementary and Integrative
Medical Therapies, Harvard
Medical School, and Division of
General Medicine and Primary
Care, Beth Israel Deaconess
Medical Center, Boston, Mass.
Dr Grahm is now with the
Department of Internal
Medicine, Mount Auburn
Hospital, Boston.
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One adult (18 years) was randomly selected from each
household to complete this portion of the survey. There were
31 044 completed interviews, with a 73.4% final weighted
response rate. The sampling methods for the NHIS are
described elsewhere.8
USE OF HERBS AND DIETARY SUPPLEMENTS
AND PRESCRIPTION MEDICATIONS
TheAlternativeMedicine Supplement solicited information from
US adults on 19 nonconventional health therapies. Respon-
dents were asked “During the past 12months, did you use natu-
ral herbs for your own health or treatment?” Of those who said
yes, respondents were asked a series of questions about spe-
cific health problems or conditions. Respondents chose from
a list of 35 dietary supplements used for health reasons (29
supplements were plant based; 6 supplements were not plant
based) (Figure). Respondents were asked if they disclosed this
use to conventional medical professionals. Finally, respon-
dents were asked if they used prescription medications in the
prior 12months. In theNHIS adult core, respondentswere asked
a series of questions about specific health problems or condi-
tions. We chose to include in our analysis 23 medical condi-
tions that had high potential of drug-NVDS interactions. These
conditions are listed in Table 1. In addition, from Table 1,
we created a “chronic conditions” variable that included 13
chronic conditions for which patients regularly use pre-
scribed medication in an attempt to ascertain concurrent use
of NVDS and prescription medication (Table 1).
OTHER HEALTH-RELATED FACTORS
We considered sociodemographic information on the respon-
dents’ age (25years, 25-34years, 35-44years, 45-54years, 55-64
years, and65 years), sex, marital status (defined as married or
notmarried), education (less thanhigh school, high school gradu-
ate, some college, and college graduate), annual family income
($15 000, $15 000-34 999, $35 000-64 999, $65 000, and
other), race/ethnicity (Hispanic, non-Hispanic white, non-
Hispanic black, non-HispanicAsian, andnon-Hispanic other [Pa-
cific Islander/NativeHawaiian andAmerican Indian/Alaskan na-
tive]) and regionofUS residence (Northeast,Midwest, South, and
West). We analyzed health care utilization data on the follow-
ing: health insurance status (insured vs not insured), usual source
ofmedical care (place for routine and preventative care), and uti-
lization of health services (last visit to health professional). We
also included self-perceived health status (excellent, very good,
good, fair, andpoor), and lifestyle/behavioral factors includeduse
of a health club, wellness program, or fitness facility in the last
year and smoking status.
STATISTICAL ANALYSIS
Population estimateswere calculated usingNHISweights, which
are calibrated to US 2000 census totals for sex, age, and race/
ethnicity of the 2002 US population. Descriptive statistics were
used to examine the prevalence ofNVDSuse and nonuse among
prescriptionmedication users, disclosure by prescriptionmedi-
cation users of NVDS to medical professionals, the most com-
mon herbs and dietary supplements used by prescriptionmedi-
cation users, and medical conditions for which NVDSs and
prescription medications were used together. We limited our
analysis of NVDS use for specific medical conditions to herbs
with high rates of popular use and/or high reported drug-herb
interactions in the literature.9,10 We used 2 tests and logistic
regression to compare proportions of characteristics in NVDS
users vs nonusers among those who took prescription medi-
cations in the prior 12months.Weused logistic regression analy-
sis to assess which variables were significantly (P.05) asso-
ciated with NVDS use among prescription medication users.
We selected variables for testing in our logistic model based
on the results of previous national studies and entered these
variables into the final model simultaneously.3 Given the prob-
lem of missing income data, we included a variable named
“other” for those with missing income data to avoid limiting
the number of respondents available for the logistic regression
analysis. Variables tested in our model are listed in Table 2.
All analyses were performed using SAS-callable SUDAAN ver-
sion 8.1 (Research Triangle Institute, Research Triangle Park,
NC)11 to account for the complex sampling design of the NHIS.
RESULTS
COMPARISON OF RESPONDENTS
USING PRESCRIPTION MEDICATIONS
WITH OR WITHOUT NVDSs
Of the 31 044 NHIS respondents, 67% used a prescrip-
tionmedication in the prior 12months (weighted for US
population 134 606 105). Of the respondents who used
prescription medications in the last year, 21% also used
anNVDSduring the same period.Of the respondentswho
did not use a prescription medication in the prior year,
16% used an NVDS. A comparison of the characteristics
of all respondents who reported use of prescriptionmedi-
cations vs those who used a prescription medication as
well as an NVDS vs those who used prescription medi-
cations but had not used an NVDS is given in Table 2.
Whenwe compared dietary supplement users with non–
dietary supplement users among respondents taking pre-
scription medications, NVDS users were more likely to
beHispanic, non-Hispanic Asian and non-Hispanic other,
uninsured, younger, female, highly educated, live in the
West, have high self-perceived health status, be a former
smoker, use a fitness center, and have no usual source
of primary care. As given in Table 2, approximately 1 in
4 prescriptionmedication users aged 45 to 55 years used
NVDSs. Nearly 30% of college-educated respondents and
Dietary Supplements
Fish Oil
Melatonin
Bee Pollen
Glucosamine Chondroitin
S-adenosylmethionine
(SAMe)
Progesterone Cream
Echinacea
Ginseng
Ginkgo biloba
Garlic Supplements
St John’s Wort
Peppermint
Ginger Supplements
Soy Supplements
Ragweed/Chamomile
Kava Kava
Valerian
Saw Palmetto
Evening Primrose
Black Cohosh
Ma Huang (Ephedra)
Licorice
Milk Thistle
Guarana
Comfrey
Feverfew
Dong Quai/Don Gui Tong
Kuei
Hawthorn
Cascara Sagrada
Yohimbe
Bladderwrack
Senna
Wild Yam Cream
Chaparral
Vitex/Chasteberry
Examples of Common Uses of Herbs Listed With Examples of Latin Names
Echinacea: To Reduce Colds and Flu Symptoms (Echinacea angustifolia)
Garlic: To Lower Cholesterol and Blood Pressure and to Act as an Antimicrobial/ 
Antifungal Agent (Allium sativum)
Ginseng: To Increase Stamina and Energy (Panax ginseng)
Ginkgo: Known for Its Memory-Enhancing Properties (Ginkgo biloba)
St John’s Wort: To Treat Mild to Moderate Depression (Hypericum perforatum)
Figure. Nonvitamin dietary supplements recorded in the National Health
Interview Survey.
(REPRINTED) ARCH INTERN MED/VOL 166, OCT 9, 2006 WWW.ARCHINTERNMED.COM
1969
©2006 American Medical Association. All rights reserved.
Downloaded From: http://archinte.jamanetwork.com/ on 02/25/2013
respondents who lived in the West used an NVDS and a
prescription medication. Nearly 1 in 5 respondents with
nousual sourceofhealthcare andno insuranceusedNVDSs
along with their prescription medication. Finally, 21% of
patients with chronic conditions reported using a dietary
supplement and prescription medication.
DISCLOSURE AND USE OF SPECIFIC NVDSs
AND PRESCRIPTION MEDICATION USE
IN THE PRIOR 12 MONTHS
Of the respondents who used both prescription medica-
tions andNVDSs in the prior 12months, 69% did not dis-
cuss this use with a conventional medical practitioner.
Among prescription medication users, menopausal
women (33%) and thosewith chronic gastrointestinal dis-
orders (28%) and severe headache ormigraine (28%) had
the highest rates of NVDS use. Prescription medication
users with congestive heart failure (13%), coronary heart
disease (12%), and history ofmyocardial infarction (12%)
had the lowest rates of NVDS use (Table 1).
Among prescription medication users with depres-
sion, 5%used St John’s wort and 6%used ginseng. Among
prescription medication users with high cholesterol
levels or irregular heart beat, 5% used garlic. Of the pre-
scription medication users with asthma, 10% used echi-
nacea (Table 1).
FREQUENCY OF SPECIFIC NVDS USE
AMONG PRESCRIPTION MEDICATION USERS
Table3demonstrates the frequencyofuseof the35single
NVDSs by respondentswhohadused prescriptionmedi-
cations in the prior 12months. Table 3 includes the rates
of specific herb use among respondents who used both
NVDSsandprescriptionmedicationintheprior12months.
FACTORS ASSOCIATED WITH NVDS USE
AMONG PRESCRIPTION MEDICATION USERS
Among prescription medication users, NVDS use was
more frequent among respondentswhowere female, ciga-
rette smokers or former smokers, and Hispanic or non-
Hispanic other; had a high school education or above;
lived in theWest compared with the Northeast; and had
chronic conditions. Among prescription medication us-
ers, factors associated with decreased use included age
older than 65 years, decreased use of a fitness center, and
living in the Midwest or South. Finally, NVDS use was
significantly more likely among respondents who were
Table 1. Use of Specific Nonvitamin Dietary Supplements (NVDSs) Among Respondents With Chronic Conditions
and Prescription Medication Use in the Prior 12 Months*
Chronic Condition
No. of Patients With
Chronic Conditions
and Prescription
Medication Use
Any
NVDS
Use, %
Echinacea
Use, %
Ginseng
Use, %
Ginkgo
Use, %
Garlic
Use, %
St John’s
Wort Use, %
Medical condition in the prior 12 mo
Menopause 1030 33.1 12.3 5.5 6.1 5.6 4.0
Insomnia 4671 26.3 9.1 6.0 5.4 5.0 4.1
Liver disease 367 25.9 8.0 5.5 6.5 4.3 1.8
Chronic pain† 4863 25.8 8.8 5.8 5.3 5.3 3.2
Depression/anxiety† 4314 25.3 8.5 6.4 5.7 4.7 4.6
Weak or failing kidneys 405 18.8 4.5 2.6 2.2 3.5 3.5
Ever been told that you had a medical condition
Chronic gastrointestinal conditions‡ 1598 28.3 9.2 5.8 5.8 5.0 3.7
Asthma† 2641 24.9 10.4 6.3 4.8 4.7 3.5
Irregular heart beat 2570 23.0 7.5 4.3 3.8 5.2 2.9
Gastrointestinal ulcer 2042 22.7 7.0 5.2 5.4 4.3 3.1
Thyroid problems† 2082 22.1 8.0 3.8 5.1 5.6 2.4
Arthritis†§ 6032 21.6 6.4 4.0 4.4 4.4 2.4
Cancer 1975 20.2 6.5 3.4 3.7 4.0 1.9
Seizure disorder† 381 19.6 8.2 6.2 5.0 5.3 4.7
Hyperlipidemia† 5610 19.6 6.4 3.4 3.8 4.7 2.0
Hypertension† 7096 17.0 5.5 3.2 3.4 3.7 1.9
Diabetes† 2040 15.3 3.3 2.6 2.1 2.9 1.2
Stroke† 731 14.0 3.2 2.8 3.4 3.4 1.7
Congestive heart failure† 541 12.9 1.9 2.0 2.9 3.1 0.3
Coronary heart disease† 1209 11.9 2.1 2.5 1.9 3.7 1.0
Myocardial infarction† 965 11.7 1.9 2.0 1.8 3.5 0.4
Medical condition in the last 3 mo
Severe headache and/or migraine 3691 27.6 11.0 6.9 5.5 5.4 4.1
Back pain 6425 25.6 9.6 6.1 5.3 4.7 3.1
*Data sources: National Health Interview Survey 20028; weighted percentages were extrapolated from the US census (2000) for the adult civilian,
noninstitutionalized, household population.
†The “chronic conditions” variable included 13 chronic conditions for which patients used daily prescribed medication.
‡Irritable bowel syndrome, inflammatory bowel disease, and severe constipation.
§Arthritis, gout, and lupus.
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Table 2. Comparison of Respondents Using Prescription Medications With or Without Nonvitamin Dietary Supplements (NVDSs)*
Characteristic
Overall Respondents Using
a Prescription Medication
in the Prior 12 Months, %
(n = 20 214)
Respondents Using
a Prescription Medication
and No NVDS in the Prior
12 Months, %
(n = 16 012)
Respondents With Concurrent
Use of a Prescription
Medication and an NVDS
in the Prior 12 Months, %
(n = 4202)†
Conditional Use Among
Prescription Medication
Users, % of Respondents
Also Using an NVDS, %
(n = 4202)
Race/ethnicity
White 78.5 78.7 77.5 20.3
Black 10.4 11.0 8.4 16.6
Asian 2.5 2.2 3.7 30.2
Other‡ 0.9 0.7 1.3 31.2
Hispanic 7.7 7.4 9.1 24.1
Age, y
24 10.6 10.6 10.4 20.2
25-34 14.9 14.5 16.7 23.0
35-44 19.0 18.6 20.8 22.5
45-54 19.7 18.7 23.3 24.3
55-64 15.0 14.8 15.8 21.6
65 20.9 22.8 13.0 12.8
Sex
Male 42.1 42.2 37.7 18.4
Female 57.9 56.8 62.3 22.1
Education level
High school 15.4 17.1 8.6 11.5
High school graduate 26.6 27.9 21.4 16.5
Some college 32.0 31.3 35.1 22.5
College graduate 25.2 22.9 34.5 28.1
Income, $
15 000 12.9 12.6 14.2 22.6
15 000-34 999 18.6 18.0 21.0 23.1
35 000-64 999 14.7 13.8 18.3 25.4
65 000 6.4 5.8 8.8 28.2
Other 47.4 49.8 37.7 16.3
Region
Northeast 19.4 19.2 20.2 21.4
Midwest 25.3 25.9 23.1 18.7
South 37.6 39.1 32.0 17.4
West 17.7 15.8 24.8 28.7
Insurance: medical
Yes 91.9 91.6 90.7 20.4
No 8.6 8.5 9.3 22.2
Usual source of medical care
Yes 94.1 94.3 93.9 20.5
No 5.8 5.7 6.1 21.5
Last visit to a health professional
6 mo 84.0 83.8 84.7 20.7
6 mo to 1 y 11.4 11.5 10.8 19.5
1 y or never saw 4.5 4.5 4.4 20.1
Self-perceived health status
Excellent, very good, or good 83.9 83.1 87.1 21.3
Fair or poor 15.9 16.8 12.8 16.4
Smoking status
Current 21.3 21.5 20.7 19.9
Former 26.4 25.9 28.4 22.1
Never 52.0 52.3 50.7 20.0
Chronic conditions§
Yes 69.1 68.9 69.9 20.8
No 30.9 31.1 30.1 20.0
Use of fitness center
Yes 63.3 61.6 69.8 29.0
No 35.6 37.2 29.4 18.3
*Data sources: National Health Interview Survey (NHIS) 20028; weighted percentages were extrapolated from the US census (2000) for the adult civilian,
noninstitutionalized, household population. Data were available for greater than 95% of the NHIS population except for the variable “income.” We did not have
complete information on 9581 respondents.
†Outcome variable combined respondents who answered yes to “during the past 12 months, did you use herbs for your own health or treatment?” and yes to
“during the past 12 months, did you use prescription medications?”
‡American Indian/Alaskan Native or Pacific Islander/Native Hawaiian.
§Chronic condition variable includes respondents with diabetes, hypertension, asthma, arthritis, depression/anxiety, coronary heart disease, hyperlipidemia,
stroke, myocardial infarction, seizure disorder, congestive heart failure, thyroid problems, and chronic pain.
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uninsured in the adjusted model (adjusted odds ratio,
1.23; 95% confidence interval, 1.06-1.43) (Table 4).
COMMENT
Of the estimated 135 million people who used prescrip-
tion medications in the last year, 21% also used an NVDS
in the prior 12months. Of the respondents who used pre-
scriptionmedications andNVDSs in the prior 12months,
69% did not discuss NVDS use with a conventional medi-
cal practitioner.Amongadultswhousedprescriptionmedi-
cations in the prior 12 months, the most commonly used
dietary supplements included echinacea, ginseng, ginkgo,
and garlic. In general, prescription medication users with
chronic but not life-threatening conditions (menopause,
chronic gastrointestinal conditions, headaches, and insom-
nia) tended to have high NVDS use, while those with
chronic and life-threatening conditions (cardiovascular dis-
ease, stroke, and diabetes) had the lowest rates of NVDS
use.WhenweexaminedNVDSuseamongrespondentswith
chronic conditions associated with regular daily prescrip-
tion medication use, we found that 21% of those respon-
dents also usedNVDSs. In the adjusted analysis, factors as-
sociated with increased use of NVDS by prescription
medication users included being female, beingHispanic or
non-Hispanic other, having more years of education,
Table 3. Frequency of Specific Nonvitamin Dietary
Supplement (NVDS) Use Among Prescription
Medication Users*
Dietary Supplement
Among Prescription
Medication and
NVDS Users,
Respondents
Reporting
Specific
NVDS Use, %
(n = 4202)
Among All
Prescription
Medication Users,
Respondents
Reporting
Specific
NVDS Use, %
(n = 20 214)
Echinacea 40.6 7.8
Ginseng 22.6 4.4
Ginkgo biloba 20.5 3.9
Garlic supplements 19.4 3.7
Glucosamine chondroitin 16.0 3.1
Black cohosh 13.0 0.7
St John’s wort 12.3 2.4
Peppermint 11.5 2.2
Fish oil 11.2 2.3
Ginger supplements 10.5 2.0
Soy supplements 10.1 1.9
Ragweed/chamomile 8.7 1.7
Bee pollen 6.7 1.4
Kava kava 6.4 1.2
Valerian 6.1 1.2
Saw palmetto 5.7 1.1
Melatonin 5.2 1.0
Evening primrose 4.3 0.9
Licorice 3.9 0.8
Ma huang (ephedra) 3.8 0.7
Milk thistle 3.5 0.7
*Data sources: National Health Interview Survey 20028; weighted
percentages were extrapolated from the US census (2000) for the adult
civilian, noninstitutionalized, household population. See the Figure for a
description of the common uses for some of the herbs listed in this table.
Table 4. Factors Associated With Nonvitamin
Dietary Supplement Use Among 20 214 Prescription
Medication Users *
Characteristic
Bivariate
Logistic
Regression, OR
(95% CI)
Adjusted OR
(95% CI)
Race/ethnicity
White 1.00 1.00
Black 0.78 (0.70-0.88) 0.90 (0.79-1.02)
Asian 1.71 (1.34-2.17) 1.31 (1.00-1.72)
Other† 1.79 (1.18-2.70) 1.74 (1.17-2.60)
Hispanic 1.25 (1.11-1.41) 1.37 (1.20-1.57)
Age, y
24 1.00 1.00
25-34 1.18 (0.99-1.40) 1.00 (0.84-1.19)
35-44 1.14 (0.97-1.34) 1.03 (0.87-1.22)
45-54 1.27 (1.08-1.49) 1.10 (0.93-1.30)
55-64 1.09 (0.92-1.29) 1.02 (0.84-1.23)
65 0.58 (0.49-0.69) 0.66 (0.54-0.81)
Sex
Male 1.00 1.00
Female 1.26 (1.16-1.37) 1.41 (1.29-1.54)
Education level
High school 1.00 1.00
High school graduate 1.52 (1.31-1.76) 1.47 (1.26-1.71)
Some college 2.23 (1.93-2.57) 1.94 (1.66-2.26)
College graduate 3.00 (2.60-3.47) 2.55 (2.16-3.02)
Income, $
15 000 1.00 1.00
15 000-34 999 1.03 (0.90-1.19) 1.00 (0.86-1.15)
35 000 64 999 1.17 (1.01-1.36) 1.04 (0.89-1.21)
65 000 1.34 (1.14-1.59) 1.07 (0.89-1.28)
Other 0.67 (0.59-0.76) 0.78 (0.68-0.89)
Region
Northeast 1.00 1.00
Midwest 0.85 (0.75-0.96) 0.86 (0.75-0.97)
South 0.78 (0.69-0.87) 0.82 (0.72-0.92)
West 1.48 (1.31-1.68) 1.43 (1.25-1.62)
Insurance: medical
Yes 1.00 1.00
No 1.12 (0.98-1.28) 1.23 (1.06-1.43)
Usual source of medical
care
Yes 1.00 1.00
No 1.06 (0.89-1.27) 1.03 (0.84-1.26)
Last visit to a health
professional
6 mo 1.04 (0.85-1.26) 1.05 (0.84-1.30)
6 mo to1 y 0.97 (0.78-1.20) 0.97 (0.77-1.22)
1 y or never saw 1.00 1.00
Self-perceived health status
Excellent, very good,
or good
1.00 1.00
Fair or poor 0.73 (0.65-0.81) 1.00 (0.88-1.14)
Smoking status
Never 1.00 1.00
Current 0.99 (0.90-1.09) 1.13 (1.02-1.26)
Former 1.13 (1.03-1.25) 1.30 (1.17-1.45)
Use fitness center
Yes 1.00 1.00
No 0.55 (0.50-0.59) 0.65 (0.59-0.72)
Chronic conditions‡
Yes 1.00 1.00
No 0.95 (0.88-1.04) 0.76 (0.68-0.84)
Abbreviations: CI, confidence interval; OR, odds ratio.
*Data sources: National Health Interview Survey 20028; weighted
percentages were extrapolated from the US census (2000) for the adult civilian,
noninstitutionalized, household population.
†American Indian/Alaskan Native or Pacific Islander/Native Hawaiian.
‡The chronic condition variable includes respondents with diabetes,
hypertension, asthma, arthritis, depression/anxiety, coronary heart disease,
hyperlipidemia, stroke, myocardial infarction, seizure disorder, congestive heart
failure, thyroid problems, and chronic pain.
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living in the West, being a cigarette smoker or former
smoker, having chronic conditions, and lacking medical
insurance. Respondents older than 65 years, those who
reported less use of a fitness center, and those living in the
Midwest or South were less likely to use an NVDS.
Amid increasing numbers of clinical reports describ-
ing interactionsbetweenprescriptiondrugs andNVDS, con-
cern has grown regarding the troubling possibility that ad-
verse effects of NVDS are underreported.9,12 Few studies
have examined theprevalenceof drug–herb/dietary supple-
ment use patterns.13-15 In our analysis, 1 in 5 prescription
medication users in the United States used NVDS in the
prior 12 months. Although we cannot be sure these data
reflectNVDSprescriptionmedication combinations taken
concurrently, more than 27 million of those living in the
United Statesmight be taking anNVDS and a prescription
medication at the same time. In 1997, an estimated 15mil-
lion people took herbal remedies and high-dose multivi-
tamins concurrently with prescription medications, with
18.4%reporting the concurrentuseof at least 1herbal prod-
uct, a high-dose vitamin, or both.16 Kaufman et al,17 in a
national survey, noted that 16% of prescription drug us-
ers also reported use of 1 or more herbal products/
supplements within the prior week. In another analysis of
the 2002 NHIS, the rate of NVDS use among elderly re-
spondentswhousedprescriptionmedicationswas 12.8%.18
However, our results are inconsistent with several ambu-
latory care studies that found rates of concurrent prescrip-
tionmedication andNVDSuse up to 43%.13,14,19,20 In agree-
mentwithour findings, other studies also found that factors
associated with NVDS use included being middle-aged,
being female, having greater than a high school educa-
tion,7,18 being uninsured,21 living in theWest,22 and using
prescriptions.17
In our study, 69% of respondents who used prescrip-
tion medications did not tell any of their conventional
medical professionals about their NVDS use. In 1997, Ei-
senberg et al16 reported that 60% of NVDS and prescrip-
tion medication users did not disclose this information
to their primary care providers. In other national and
smaller cross-sectional surveys, approximately 35% to44%
of thosewho take dietary supplements regularly did share
this information with a health care provider.16,23
As shown in Table 1, prescription medication users
with chronic but not life-threatening conditions tended
to have high NVDS use. Those with chronic and pos-
sible life-threatening conditions tended to have the low-
est rates of NVDS use. In the adjusted model, patients
with chronic conditions requiring daily prescriptionmedi-
cations had the higher rates of NVDS use.
There are certain patientswith chronic illnesswhomay
be more susceptible to NVDS and prescription medica-
tion interactions, such as thosewith liver disease and kid-
ney disease because of their limited ability to metabo-
lize NVDSs or prescriptionmedications. Despite this, we
found that 26% of patients with liver disease and 19% of
patients with kidney diseasewere usingNVDSs and a pre-
scription medication in the prior 12 months. Unfortu-
nately, there is little evidence to provide clinicians with
guidance on the safety of NVDS use in patients with liver
and kidney disease. In addition, there is concern about
potential interactions among patients taking prescrip-
tionmedicationswith narrow therapeutic indexes of safety
such as valproic acid,warfarin, anddigoxin.24 In our analy-
sis, patients with seizure disorders, irregular heart beats,
and congestive heart failure had relatively highNVDS use
(20%, 23%, and 13%, respectively).
Manyof the herbs anddietary supplements asked about
in the NHIS such as chamomile and peppermint are safe
for consumption. Yet, among theherbs anddietary supple-
ments asked about in theNHIS, several are known to have
well-documented drug-herb interactions. For example,
an estimated 1.2 million prescription medication users
with depression used St John’s wort in the prior 12
months. St John’s wort has been shown to lower the
plasma concentration (and/or the pharmacological effect)
of a number of drugs including alprazolam, amitripty-
line, cyclosporine, digoxin, fexofenadine, indinavir, iri-
notecan, methadone, nevirapine, simvastatin, tacroli-
mus, theophylline, warfarin, phenprocoumon, and oral
contraceptives.25,26 Induction of P-glycoprotein and/or cy-
tochrome P450 (CYP) enzymes (particularly CYP 3A4)
by St John’s wort could explain such pharmacokinetic
interactions. Therefore, physicians must be aware that
patients taking St John’s wort run the risk of having sub-
therapeutic blood levels of drugs such as antirejection
and human immunodeficiency virusmedications.When
combined with serotonin reuptake inhibitors, St John’s
wort may cause serotonergic syndrome.27
Althoughmany of the 35NVDS listed in the NHIS are
safe for consumption, several may have underlying toxic
effects and are particularly dangerous for patients with
underlying chronic diseases such as heart disease or liver
failure. For example, ephedra was used by approxi-
mately 4% of the users of both prescription medications
and NVDSs. Subsequent to the 2002 NHIS, in 2003 the
US Department of Health and Human Services banned
the sale of ephedra after concluding that the risks asso-
ciated with the use of ephedra for weight loss and sports
enhancement outweighed the potential benefits.28 How-
ever, ephedra is back on themarket inweight loss supple-
ments because the banwas overturned.29 Kava kava, used
by approximately 6% of the users of both prescription
medications and NVDSs, has been linked with hepato-
toxicity and prompted regulatory agencies in the United
States, Germany, Switzerland, France, Canada, and the
UnitedKingdom to take action ranging fromwarning con-
sumers about the potential risks to removing kava-
containing products from the marketplace.30
There are several limitations to our analysis. First, the
survey is based on self-reported data; thus, subjects may
be underreporting or overreporting their use of NVDSs.
Second, we are unable to ascertain the exact proportion
of respondents taking NVDSs and prescription medica-
tion concurrently. However, when we examined the rate
of NVDS use among respondents with chronic condi-
tions associatedwith regularmedication use, the rate was
also 21%. Third, the term natural herbs, which was used
in the NHIS question (rather than dietary supplement,
herbal product, or nonvitamin dietary supplement) may
have been misunderstood by respondents. Respondents
who took a dietary supplement such as glucosaminemay
not have responded positively to the question do you take
a “natural herb,” thus underreporting nonherbal di-
(REPRINTED) ARCH INTERN MED/VOL 166, OCT 9, 2006 WWW.ARCHINTERNMED.COM
1973
©2006 American Medical Association. All rights reserved.
Downloaded From: http://archinte.jamanetwork.com/ on 02/25/2013
etary supplement use. Fourth, the survey listed only 35
NVDSs, although there are thousands of NVDSs sold as
sport supplements, weight loss products, combination di-
etary supplements, or ethnic traditional medicines in the
United States, which may lead to underreporting. Fi-
nally, many dietary supplements have unique common
names based on the region or cultural background of the
respondents, and the 35 dietary supplementsmay not in-
clude supplements unique to any one culture, perhaps
leading to an ethnocentric andmedicocentric bias in the
survey instrument, whichmay have contributed to an un-
derestimation of the prevalence of NVDS use, especially
among nonwhite ethnic groups
Given the high frequency of NVDS and prescription
medication use, physicians need to be cognizant of po-
tential adverse effects or interactions associated with any
prescribedmedicationorNVDS.Dietary supplements have
complex mechanisms of actions and complicated phar-
macokinetics, which need to be better understood. Health
care professionals must regularly ask their patients with
chronic conditions and prescription medications about
NVDS use. More research on drug-herb interactions and
postsurveillance studies are critically needed.
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